Adjusting the radioisotope tracer dose according to the body mass index does not enhance the visualization of axillary sentinel lymph nodes

Acta Radiologica

Volumn 47, Issue 7, 2006, Pages 646-649

  Leikola, J P ^a,b   Leppanen E A ^a   Von Smitten, K A J ^a   Leidenius, M H K ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE   (Finland)

Author keywords

Breast; Radionuclide studies; Surgery

Indexed keywords

BIOLOGICAL ORGANS; BIOPSY; PATIENT MONITORING; RADIOACTIVE TRACERS; TUMORS;

BODY MASS INDEX (BMI); BREAST CANCER; LYMPHOSCINTIGRAPHY (LS); RADIONUCLIDE STUDIES;

DOSIMETRY;

MACROSALB TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M NANOCOLLOID;

ADULT; ARTICLE; AXILLA; BODY MASS; BREAST TUMOR; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; LYMPH NODE METASTASIS; NONPARAMETRIC TEST; PATHOLOGY; SCINTISCANNING;

ADULT; AXILLA; BODY MASS INDEX; BREAST NEOPLASMS; HUMANS; INJECTIONS, INTRALESIONAL; LYMPHATIC METASTASIS; RADIOPHARMACEUTICALS; STATISTICS, NONPARAMETRIC; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 33748484458     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850600791542     Document Type: Article

References (12)

1. Chagpar A, Martin RC 3rd, Chao C, Wong SL, Edwards MJ, Tuttle T, et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg 2004;139:614-18.
2. Cox CE, Dupont E, Whitehead GF, Ebert MD, Nguyen K, Peltz ES, et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J 2002;8:88-91.
3. Derossis AM, Fey JV, Cody HS 3rd, Borgen PI. Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer. J Am Coll Surg 2003;197:896-901.
4. Edwards TL. Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania. Aust NZ J Surg 2000;70:412-18.
5. Leppänen E, Leidenius M, Krogerus L, von Smitten K. The effect of patient and tumour characteristics on visualization of sentinel nodes after a single intratumoural injection of Tc 99m labelled human albumin colloid in breast cancer. Eur J Surg Oncol 2002;28:821-6.
6. Martin RC, Derossis AM, Fey J, Yeung H, Yeh SD, Akhurst T, et al. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery 2001;130:432-8.
7. McMasters KM, Wong SL, Martin RC 2nd, Chao C, Tuttle TM, Noyes RD, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 2001;233:676-87.
8. Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004;187:69-72.
9. Roumen RM, Geuskens LM, Valkenburg JG. In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol 1999;25:347-51.
10. Rönkä R, Krogerus L, Leppänen E, von Smitten K, Leidenius M. Radio-guided occult lesion localization in patients undergoing breast-conserving surgery and sentinel node biopsy. Am J Surg 2004;187:491-6.
11. Sato K, Tamaki K, Shigekawa T, Tsuda H, Kosuda S, Kusano S, et al. Clinicopathologic and technical factors associated with the uptake of radiocolloid by sentinel nodes in patients with breast cancer. Surg Today 2003;33:403-7.
12. Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 2001;192:684-9.